Back to top

Image: Bigstock

ProQR Therapeutics (PRQR) Worth a Look: Stock Up 9.8%

Read MoreHide Full Article

ProQR Therapeutics N.V. (PRQR - Free Report) was a big mover last session, as the company saw its shares rise nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down nearly 19% in the past one-month time frame.

The company has seen no estimate revisions over the past 7 days, while the Zacks Consensus Estimate remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

ProQR Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

A better-ranked stock in the same industry is BioMarin Pharmaceutical Inc. (BMRN - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is PRQR going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand.  Click to see them now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


BioMarin Pharmaceutical Inc. (BMRN) - free report >>

ProQR Therapeutics N.V. (PRQR) - free report >>

Published in